Join to View Full Profile
160 East 53rd StreetNew York, NY 10022
Dr. Thummalapalli is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
Johns Hopkins UniversityResidency, Internal Medicine, 2018 - 2021
Harvard Medical SchoolClass of 2017
Certifications & Licensure
NY State Medical License 2021 - 2026
NJ State Medical License 2024 - 2025
American Board of Internal Medicine Internal Medicine- American Board of Internal Medicine Medical Oncology
Publications & Presentations
PubMed
- Factors Associated with Disease Progression after Discontinuation of Immune Checkpoint Inhibitors for Immune-Related Toxicity in Patients with Advanced Non-Small Cell ...Federica Pecci, Rohit Thummalapalli, Stephanie L Alden, Biagio Ricciuti, Joao V Alessi
Clinical Cancer Research. 2025-04-18 - Germline prediction of immune checkpoint inhibitor discontinuation for immune-related adverse events.Pooja Middha, Rohit Thummalapalli, Zoe Quandt, Karmugi Balaratnam, Eduardo Cardenas
Journal for Immunotherapy of Cancer. 2025-03-28 - 2 citationsPan-cancer analysis of biallelic inactivation in tumor suppressor genes identifies KEAP1 zygosity as a predictive biomarker in lung cancer.Mark Zucker, Maria A Perry, Samuel I Gould, Arielle Elkrief, Anton Safonov
Cell. 2025-02-06
Journal Articles
- Tumor Innate Immunity Primed by Specific Interferon-Stimulated Endogenous RetrovirusesScott Rodig, Ewa Sicinska, Thanh Uyen Barbie, David Allen Barbie, Russell William Jenkins, Ravindra Uppaluri, Rohit Thummalapalli, Jacob Sands, Nature
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
